Content is provided by the firm.
Heim, Payne &
Chorush L.L.P. specializes exclusively in intellectual property litigation and
antitrust lawsuits involving intellectual property.
The firm represents
plaintiffs and defendants nationwide in a broad range of technologies including
microprocessors, computer architecture, memory control systems, cellular
telephone systems, data transmission systems, internet radio, database caching
software, on-line gaming systems, computer-controlled lighting,
pharmaceuticals, drilling and other downhole systems, stents and natural gas
conversion systems. The trial team has a wide variety of technical backgrounds
and the expertise to handle all facets of intellectual property litigation,
appeals at the Federal Circuit, and post-grant proceedings. Heim, Payne & Chorush
has earned a reputation for handling every aspect of the most complicated
patent disputes for some of the largest energy and technology firms. In
addition, the firm often represents individuals and smaller companies against
behemoths of industry.
All of the firm’s trial
lawyers have scientific or technical degrees, and many have completed
clerkships at federal trial and appellate courts. The trial team is diligent and hard-working and does not let any
potential argument go untested. They are willing to dig into the details of the
technology at issue, gaining an expert level of comfort with the technology
that proves invaluable in patent litigation. Clients, which include patent
owners as well as companies accused of patent infringement, look to the firm to
draw on this well of technical and legal experience to provide the
patent-focused results they seek.
The firm is recognized
by Chambers USA in Intellectual Property Litigation, by IAM in the Patent 1000
– the world's leading patent professionals, and is ranked among the Best Law
Firms in IP Litigation and Patent Litigation by US News & World Report and Best Lawyers. Heim,
Payne & Chorush takes pride in its ability to partner with other attorneys
and firms to bring the best possible trial team together for the benefit of the